The Food and Drug Administration said it will ask Illinois for more information on safeguards against counterfeit products in a state plan to help residents buy lower-cost drugs from suppliers in the United Kingdom, Ireland and Canada. Illinois Gov. Rod Blagojevich gave the FDA an 84-page report on the plan, but FDA Associate Commissioner William Hubbard said key details were left out. Opening the door to prescription drugs from the U.K. leaves it propped open for sketchier drug imports from less-developed countries, Hubbard said. Latvia and Estonia, for example, could turn into gateways for products made in other countries known for drug counterfeiting, he said. A spokeswoman for Blagojevich dismissed such concerns. The drugs Illinois will import are all FDA-approved, which means they are made at manufacturing plants the agency already inspects, she said. The drugs also must be packaged and labeled in English for distribution in the U.K, Ireland or Canada, she said. -- by the Associated Press
FDA to seek more details on Ill. drug-import plan
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.